Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 ,inter alia, to consider and approve 1. To convene the 6th Annual General Meeting of the Company and approve the draft notice and explanatory statement;\r\n2. To consider and approve the draft report of the Board together with the Management Discussion and Analysis Report forming part of the Annual report for the year ended 31st March, 2025;\r\n3. Any other incidental matters.\r\n